Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters

Synapse

Volumn 56, Issue 2, 2005, Pages 100-104

  Ghose, Subroto ^a,f   Fujita, Masahiro ^a   Morrison, Paul ^b   Uhl, George ^c   Murphy, Dennis L ^a   Mozley, P David ^d   Schou, Magnus ^e   Halldin, Christer ^e   Innis, Robert ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoradiography; Binding assay; Knockout mice; NET

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 2 [ALPHA (2 METHOXYPHENOXY)BENZYL]MORPHOLINE; CITALOPRAM; DESIPRAMINE; DOPAMINE TRANSPORTER; FLUVOXAMINE; LIGAND; METHYLPHENIDATE; MORPHOLINE DERIVATIVE; NISOXETINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; BRAIN HOMOGENATE; CONTROLLED STUDY; DISSOCIATION; DRUG PROTEIN BINDING; DRUG SPECIFICITY; HETEROZYGOSITY; HOMOZYGOSITY; HYPOTHALAMUS; IN VITRO STUDY; KNOCKOUT MOUSE; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STRIA TERMINALIS; THALAMUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CITALOPRAM; COMPETITIVE BIDDING; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MICE; MICE, KNOCKOUT; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PHENOLS; PIPERAZINES; PROTEIN BINDING; RADIOPHARMACEUTICALS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS; TISSUE DISTRIBUTION;

EID: 15244360828     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20133     Document Type: Article

References (18)

1. 3H]-Desipramine-binding sites in human postmortem brain tissue. Neuropsychobiology 23:68-73.
2. Blakely RD, De Felice LJ, Hartzell HC. 1994. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196: 263-281.
3. Coulter CL, Happe HK, Murrin LC. 1996. Postnatal development of the dopamine transporter: a quantitative autoradiographic study. Brain Res Dev Brain Res 92:172-181.
4. Ding YS, Lin KS, Garza V, Carter P, Alexoff D, Logan J, Shea C, Xu Y, King P. 2003. Evaluation of new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse 50:345-352.
5. Franklin KB, Paxinos G. 1997. The mouse brain in stereotactic coordinates, 2nd ed. San Diego: Academic Press.
6. Fuxe K. 1965. Evidence for the existence of monoamine containing neurons in the central nervous system. IV. The distribution of monoamine terminals in the central nervous system. Acta Physiol Scand 64(Suppl 247):39-85.
7. Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD. 1995. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter- transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198:2197-2212.
8. 3H]desmethylimipramine binding in the human brain post-mortem. Brain Res 456:120-126.
9. Grzanna R, Molliver ME. 1980. The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience 5:21-402.
10. 11C nisoxetine, a norepinephrine transporter inhibitor. Nucl Med Biol 16:771-774.
11. Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR. 2002. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115:153-161.
12. Melloni P, Carniel G, Della Torre G, Bonsignori A, Buonamici M, Pozzi O, Ricciardi S, Rossi AC. 1984. Potential antidepressant agents α-aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur J Med Chem Chim Ther 19:235-242.
13. Ohman D, Norlander B, Peterson C, Bengtsson F. 2001. Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC. Ther Drug Monit 23:27-34.
14. Revay R, Vaughan R, Grant S, Kuhar MJ. 1996. Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22:93-99.
15. Schou M, Halldin C, Sovago J, Pike VW, Gulyas B, Mozley PD, Johnson DP, Hall H, Innis RB, Farde L. 2003. Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nucl Med Biol 7:707-714.
16. Sur C, Betz H, Schloss P. 1996. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73:217-231.
17. 3H]Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharm Exp Ther 260:427-436.
18. Wilson A, Johnson DP, Mozley D, Hussey D, Ginovart N, Nobrega J, Garcia A, Meyer J, Houle S. 2003. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. Nucl Med Biol 30:85-92.